Copyright © Inderes 2011 - present. All rights reserved.

Magle Chemoswed Holding

29.4

 

SEK

 

-2 %

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Compare
-2%
-5.77%
-15.52%
-15.52%
-23.93%
-8.34%
+2.13%
-
+46.32%

The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.

Read more
Market cap
603.17M SEK
Turnover
23.46K SEK
Revenue
236.04M
EBIT %
9.84 %
P/E
0.67
Dividend yield-%
-
Financial calendar
26.5
2025

General meeting '25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.